We hope so!
On June 12 we sent all our members an email that contains a button that navigates our members to their own personalized link to our National Report Card (NRC) survey.
If you didn’t see it and would like to search your inbox, the email is from HAE Canada staff member’s email address (ddumbrille@haecanada.org). We can appreciate that some people may have a strong firewall, so we recently sent a follow up email to help ensure our message lands in everyone’s inbox. If you didn’t get our first email, you may receive the reminder email that we will send in a few weeks.
If you are not able to locate your survey, please contact your Regional Director or Daphne (office@haecanada.org) and request a link to our NRC survey.
Thank you to everyone who has already filled out the survey and to those planning to fill it out shortly. Your participation is extremely important as it allows HAEC to advocate on behalf of all HAE Canada members.
Latest News
CBS Announces Results of the RFP for PPRP
Canadian Blood Services (CBS) Announces the Results of the Request for Proposals (RFP) for Plasma-Derived
The 2022 Virtual Global Walk
To celebrate hae day 🙂 over 5,000 people around the world contributed their steps to the
Health Canada Approves ORLADEYO
We are thrilled to share BioCryst Pharmaceutical's big announcement: Health Canada has approved their oral,
Takeda Canada Awarded Tender for TAKHZYRO
Héma-Québec, the organization in Quebec that manages blood and biological products, has awarded a
HAEi Advocacy Academy
HAE International is offering free, online advocacy courses. This extremely comprehensive program is designed to support people with
Our Next Patient Information Update: November 20, 2021
Please join us on Saturday November 20th from 1:00-3:00pm ET for our next Update! Details
Notice of the 2021 AGM
We hope you can join us for our 2021 AGM. Please check your inbox for
Save the Date: Nov 20, 2021
Please mark your calendars! HAE Canada is hosting a Virtual Patient Information Update on November
Lanadelumab Added to NS Formulary
Lanadelumab (TAKHZYRO), a treatment to routinely prevent attacks in patients with HAE Type I or
Congratulations Heather Dow
Who is Heather Dow? Heather has been supporting HAE Canada in many ways over the
Support Family Testing
Give valuable insights in HAE science
Hereditary Angioedema (HAE) is a hereditary disorder. It is therefore very important to have other family members tested. To help you in this process HAE International has developed two documents for patients. You can download the documents below:
